Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Hal who wrote (3537)	5/20/1998 9:29:00 AM
From: Michael Brey	Read Replies (1) \| Respond to of 3906

Maybe the next announcement will be to tell us who our major industry partner is going to be. I am sure they are lining up as HVSF's door. It is the belief of the Company that if an agreement with a major industry partner can be secured, the possibility exists that the regulatory process for its products could be expedited. This should greatly enhance the Company's ability to bring its products to market more quickly, thus insuring the Company an opportunity to maximize its profitability from the remaining life of its patent for its products which was issued February 17, 1998. Without the benefit of an industry partner, the Company believes that an 18 to 24 month time-line to obtain regulatory approval is the current assumption, but there can be no assurance, if ever, that the product will receive FDA approval in that time span.